ArticleUrologic oncology2026

Real-world outcomes of nadofaragene firadenovec for BCG-unresponsive non-muscle-invasive bladder cancer: A multicenter experience.

Jacob A Moyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.